Ana Santos Rutschman

2025-09-10 01:54:45

(MENAFN- The Conversation)

Professor of Law, Villanova University

Profile Articles Activity

Ana Santos Rutschman is a professor of law at Villanova University, where she teaches courses in health law, intellectual property, and regulation in the life sciences. She researches and writes on topics related to emerging health technologies, with a particular focus on vaccines and other forms of biotechnology. She has also published on topics related to e-health, global public health and artificial intelligence. She has spoken on these topics in conferences and panels around the world. In 2015-16, she consulted for the World Health Organization on matters related to the development of the Ebola and Zika vaccines. In 2017, she was named a Bio IP Scholar by the American Society of Law, Medicine & Ethics, and in 2018 she was named a Health Law Scholar by the same institution.

Experience

2022–present Professor, Villanova University
2018–2022 Assistant Professor, Saint Louis University School of Law
2016–2018 Faculty Fellow in Health Law and Intellectual Property, DePaul University College of Law

Education

2016 Duke Law School, SJD
2008 Duke Law School, LLM in Intellectual Property

Publications

2022 Vaccines as Technology, Cambridge University Press
2021 The Case Against Monetary Behavioral Incentives in the Context of COVID-19 Vaccination (with Timothy Wiemken), Harvard Public Health Review
2021 Property and Intellectual Property in Vaccine Markets, Texas A&M Property Law Journal
2021 Intellectual Property as a Determinant of Health, Vanderbilt Journal of Transnational Law
2021 Social Media Self-Regulation and the Rise of Vaccine Misinformation, University of Pennsylvannia Journal of Law and Innovation
2021 Vaccine Clinical Trials and Data Infrastructure, Utah Law Review
2021 Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic (with Timothy Wiemken), Vaccine
2021 Is There a Cure for Vaccine Nationalism?, Current History
2021 The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation, Washington University Journal of Law and Policy
2020 The Reemergence of Vaccine Nationalism, Georgetown Journal of International Affairs Online
2020 Regulatory Malfunctions in the Drug Patent Ecosystem , Emory Law Journal
2020 The Intellectual Property of Vaccines: Takeaways from Recent Infectious Disease Outbreaks, Michigan Law Review Online
2020 A Machine Learning Primer for Infection Prevention and Control (with Timothy Wiemken), American Journal of Infection Control
2019 On the Judicialization of Health, Washington University Global Studies Law Review
2019 The Vaccine Race in the 21st Century, Arizona Law Review
2018 IP Preparedness for Outbreak Diseases, UCLA Law Review
2018 Vaccine Licensure in the Public Interest: Lessons from the Development of the US Army Zika Vaccine, Yale Law Journal Forum
2017 The Priority Review Voucher Program at the FDA: From Neglected Tropical Diseases to the 21st Century Cures Act, Annals of Health Law

Honours

2017 Bio IP Scholar (American Society of Law, Medicine & Ethics); 2018 Health Law Scholar (American Society of Law, Medicine & Ethics); 2019 Manzo Scholar in Patent Law; 2019 Fellow (CIPPM/Jean Monnet Centre of Excellence for European Intellectual Property and Information Rights); 2022: 40 Under 40 Public Health Catalyst Award, Boston Congress on Public Health

MENAFN09092025000199003603ID1110039313

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.